Hair repigmentation associated with the use of brentuximab
Main Authors: | Lauren R. Penzi, MD, Athena Manatis-Lornell, BA, Arturo Saavedra, MD, PhD, David Fisher, MD, PhD, Maryanne M. Senna, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-11-01
|
Series: | JAAD Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512617302369 |
Similar Items
-
Hair repigmentation in microcystic adnexal carcinoma
by: Ryan C. Saal, BS, et al.
Published: (2023-05-01) -
Brentuximab vedotin induced uveitis
by: Stijn Therssen, M.D., et al.
Published: (2022-06-01) -
Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma
by: Susan Y. Wu, MD, et al.
Published: (2023-11-01) -
Severe Insulin Resistance with Diabetic Ketoacidosis After Brentuximab Treatment
by: Janet M. Chiang, MD, et al.
Published: (2020-03-01) -
Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation
by: Gustavo Villarreal-Reyna, et al.
Published: (2022-11-01)